参考文献/References:
[1] COLLINS P Y,PATEL V,JOESTL S S,et al.Grand challenges in global mental health[J].Nature,2011,475(7354):27-30.
[2] YUE W H,WANG H F,SUN L D,et al.Genome-wide association study identifies a susceptibility locus for schizophrenia in Han Chinese at 11p11.2[J].Nature Genetics,2011,43(12):1228-1231.
[3] World Health Organization.The global burden of disease:2004 up-data[EB/OL]. [2017-10-16].http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/.
[4] SULLIVAN P F,KENDLER K S,NEALE M C.Schizophrenia as a complex trait:evidence from a meta-analysis of twin studies[J].Arch Gen Psychiatry,2003,60:1187-1192.
[5] EVANS J D,BOND G R,MEYER P S,et al.Cognitive and clinical predictors of success in vocational rehabilitation in schizophrenia[J].Schizophr Res,2004,70(2/3):331-342.
[6] TSUANG M T,TOHEN M.Text book in Psychiatric Epidemiology[M].New York:Wiley Black well,2011:264-265.
[7] VENTURA J,HELLEMANN G S,THAMES A D,et al.Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia:a meta-analysis[J].Schizophr Res,2009,113(2/3):189-199.
[8] BAHCECI B,KOKACYA M H,COPOGLU U S,et al.Elevated nucleosome level and oxidative stress in schizophrenia patients[J].Bratisl Lek Listy,2015,116(10):587-590.
[9] 张宏耕,陈裕根,宋炜熙,等.990例精神分裂症患者中医证候构成比分析[J].湖南中医药大学学报,2011,31(5):57-59.
[10] KAY S R,FISZBEIN A,OPLER L A.The positive and negative syndrome scale(PANSS) for schizophrenia[J].Schizophr Bull,1987,13(2):261-276.
[11] 张伟,史振华,陈旭梅,等.首发精神分裂症患儿认知功能损害的研究[J].中华实用儿科临床杂志,2013,28(17):1347-1350.
[12] 李光辉,向乾龙.100例精神分裂症精神症状与中医辨证关系分析[J].现代医药卫生,2004,20(23):2552-2552.
[13] 李振光,张宏耕,张臣.精神分裂症中医证型与证候特点分析[J].中医药信息,2007,24(6):24-26.
[14] COUTURE S M,GRANHOHN E L,FISH S C.A path model investigation of neurocongition,theory of mind,social competence,negative symptoms and real-world functioning in schizophrenia[J].Schizophr Res,2011,125(2/3):152-160.
[15] 刘璇,王惠玲,方悦,等.精神分裂症首次发病患者的执行功能和学习能力[J].中华精神科杂志,2011,44(1):32-35.
[16] 谭淑平,邹义壮,崔界峰,等.正常人群精神分裂症认知功能成套测验共识版得分的年龄效应[J].中国心理卫生杂志,2013,10(27):776-779.
[17] HARVEY P D,RABINOWITZ J,EERDEKENS M,et al.Treatment of cognitive impairment in early psychosis:a comparison of risperidone and haloperidol in a large long-term trial[J].Am J Psychiatry,2005,162(10):1888-1895.
[18] 李本亮,杨永锋,张红星,等.成年早期起病精神分裂症患者脑白质弥散张量研究[J].新乡医学院学报,2017,34(11):974-977.
[19] 王彦芳,李素萍,杜巧荣,等.首发精神分裂症患者认知功能损与不同精神症状的相关性研究[J].中华临床医师杂志,2015,9(5):747-750.
[20] 姚明荣,胡健波.精神分裂症认知功能成套测验在首发精神分裂症患者中的应用研究[J].中国现代医生,2015,53(21):14-17.
相似文献/References:
[1]黄远学,王长虹,苏秀芝,等.77例出院后精神分裂症患者心理调查分析[J].新乡医学院学报,1994,11(03):227.
[2]娄百玉,石玉中,韩巍巍,等.未婚女精神分裂症患者父母的心理分析 [J].新乡医学院学报,1994,11(04):375.
[3]郭素芹,吕路线,郭云,等.一次量氯氮平对精神分裂症患者脑电活动的影响[J].新乡医学院学报,1997,14(02):122.
[4]查彩慧 郭国庆.氯丙嗪氯氮平合用治疗精神分裂症临床疗效评价[J].新乡医学院学报,1999,16(04):311.
[5]郭慧荣,张绍荣. 孙富根.利培酮与氯氮平治疗精神分裂症的临床对照研究[J].新乡医学院学报,2001,18(03):174.
[6]李彩霞,张钰,何艳.冬季和夏季出生的精神分裂患者的临床差异[J].新乡医学院学报,2001,18(05):348.
[7]杜云红,郝以辉,王新友.儿童期精神分裂症预后的影响因素分析[J].新乡医学院学报,2001,18(01):058.
[8]扬世昌,祁富生,张疆丽.利培酮治疗精神分裂症2O例[J].新乡医学院学报,2002,19(02):113.
[9]王长虹,李 晏,贾福军,等.工、Ⅱ型精神分裂症患者血清免疫指标的对照分析[J].新乡医学院学报,2002,19(05):360.
[10]孙富根,杜云红,董瑞兰.精神分裂症患者智商和P3o0电位的关系[J].新乡医学院学报,2002,19(05):376.